MBX.TO

Healthcare Biotechnology

Microbix Biosystems Inc.

CA$0.30

-0.01 -3.23% today

Price History

Not enough data

Key Stats

Market Cap

41.09M

Avg Volume

26,064

EPS

-CA$0.04

52W High

CA$0.33

52W Low

CA$0.21

Div. Yield

0.0%

Analyst Ratings

Strong Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

15.00

P/B Ratio

1.69

P/S Ratio

2.67

EV/EBITDA

-13.30

EV/Revenue

2.64

Margins

Gross Margin 45.9%

Operating Margin (16.2%)

Net Margin (31.7%)

EBITDA Margin (19.8%)

Growth & Returns

Revenue Growth (YoY)

16.9%

Return on Equity

(18.2%)

Return on Assets

(7.4%)

Liquidity & Leverage

Current Ratio

6.89

Quick Ratio

3.17

Debt / Equity

0.28

Total Cash

7.16M

Total Debt

6.72M

About

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.